|
|
||||||||
1Department of Kinesiology, College of Health and Human Performance, University of Maryland, College Park, Maryland; and 2Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania
Submitted 30 July 2004 ; accepted in final form 27 December 2004
Strength training (ST) is considered an intervention of choice for the prevention and treatment of sarcopenia. Reports in the literature have suggested that the insulin-like growth factor I protein (IGF-I) plays a major role in ST-induced skeletal muscle hypertrophy and strength improvements. A microsatellite repeat in the promoter region of the IGF1 gene has been associated with IGF-I blood levels and phenotypes related to IGF-I in adult men and women. To examine the influence of this polymorphism on muscle hypertrophic and strength responses to ST, we studied 67 Caucasian men and women before and after a 10-wk single-leg knee-extension ST program. One repetition maximum strength, muscle volume via computed tomography, and muscle quality were assessed at baseline and after 10 wk of training. The IGF1 repeat promoter polymorphism and three single-nucleotide polymorphisms were genotyped. For the promoter polymorphism, subjects were grouped as homozygous for the 192 allele, heterozygous, or noncarriers of the 192 allele. After 10 wk of training, 1-repetition maximum, muscle volume, and muscle quality increased significantly for all groups combined (P < 0.001). However, carriers of the 192 allele gained significantly more strength with ST than noncarriers of the 192 allele (P = 0.02). There was also a nonsignificant trend for a greater increase in muscle volume in 192 carriers than noncarriers (P = 0.08). No significant associations were observed for the other polymorphisms studied. Thus these data suggest that the IGF1 promoter polymorphism may influence the strength response to ST. Larger sample sizes should be used in future studies to verify these results.
muscle volume; muscle quality
This article has been cited by other articles:
![]() |
B. D. Hand, M. C. Kostek, R. E. Ferrell, M. J. Delmonico, L. W. Douglass, S. M. Roth, J. M. Hagberg, and B. F. Hurley Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults J Appl Physiol, November 1, 2007; 103(5): 1678 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vogiatzis, G. Stratakos, D. C M Simoes, G. Terzis, O. Georgiadou, C. Roussos, and S. Zakynthinos Effects of rehabilitative exercise on peripheral muscle TNF{alpha}, IL-6, IGF-I and MyoD expression in patients with COPD Thorax, November 1, 2007; 62(11): 950 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Devaney, E. P. Hoffman, H. Gordish-Dressman, A. Kearns, E. Zambraski, and P. M. Clarkson IGF-II gene region polymorphisms related to exertional muscle damage J Appl Physiol, May 1, 2007; 102(5): 1815 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Delmonico, M. C. Kostek, N. A. Doldo, B. D. Hand, S. Walsh, J. M. Conway, C. R. Carignan, S. M. Roth, and B. F. Hurley Alpha-Actinin-3 (ACTN3) R577X Polymorphism Influences Knee Extensor Peak Power Response to Strength Training in Older Men and Women J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2007; 62(2): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hovind, S. Lamberts, W. Hop, J. Deinum, L. Tarnow, H.-H. Parving, and J. A M J L Janssen An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes Eur. J. Endocrinol., January 1, 2007; 156(1): 83 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rietveld, M. K. Ikram, J. R. Vingerling, A. Hofman, H. A.P. Pols, S. W.J. Lamberts, P. T.V.M. de Jong, C. M. van Duijn, and J. A.M.J.L. Janssen An igf-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes, August 1, 2006; 55(8): 2387 - 2391. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |